Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Assessing MSL Effectiveness: A Three-Pronged Strategy

Posted by Sunil John on Mon, Feb 04, 2019

As most of us in pharma know, the medical science liaison (MSL) role is purely scientific, educational and non-promotional, making it difficult for medical and company leadership to assess its performance. Compared to the sales function, companies continue to struggle with developing an assessment plan that can accurately benchmark MSL performance. Many organizations that we have worked with also face challenges in articulating the value of this critical role, and their assessments are qualitative rather than quantitative and results-driven.

Read More

Topics: key online influencers, medical science liaisons, medical affairs outlook report, medical affairs

Physicians, Payers and Patients Want Evidence, and Med Affairs Knows How to Deliver

Posted by Pratap Khedkar on Wed, Jan 16, 2019

As the pharmaceutical industry continues to stack up scientific breakthroughs, there’s a growing need for experts within pharma organizations who can articulate deep disease knowledge, link clinical results to outcomes, and demonstrate product value. As luck would have it, a small department that’s well suited to the task has steadily been building its capabilities and expanding its reach into new areas. Medical affairs, once a little-known entity, is making its mark on the industry, but if leveraged properly, its impact could be even greater.

Read More

Topics: Pratap Khedkar, healthcare ecosystem, Sarah Jarvis, medical science liaisons, clinical evidence, collaboration, drug development and commercial, medical affairs, communicate scientific complexity

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.